TP53 and B-cell chronic lymphocytic leukemia: Interestingly, cases carrying TP53 aberrations showed significantly higher EB versus TP53-wildtype CLL cases (median-EB = 45,848.5 vs 42,384, respectively, p = 0.0176) (Fig. 3d).